Journal of Clinical Epidemiology
Volume 56, Issue 1 , Pages 17-27 , January 2003

Major adverse outcomes after percutaneous transluminal coronary angioplasty: a clinical prediction rule

  • Elizabeth B Fortescue

      Affiliations

    • Division of General Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Neville House Room 341, 75 Francis Street, Boston, MA 02115, USA
    • ,
  • Katherine Kahn

      Affiliations

    • Divisions of General Internal Medicine and Health Services Research, UCLA Medical Center, B-976 Factor Building, 10833 La Comte Ave., Los Angeles, CA, 90095-173 USA
    • ,
  • David W Bates

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: 617- 732-7063; fax: 617-732-7072.
    • Division of General Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Neville House Room 341, 75 Francis Street, Boston, MA 02115, USA

Received 29 October 2001 ,Revised 4 June 2002 ,Accepted 5 September 2002.

References 

  1. Fortescue EB, Kahn K, Bates DW. Prediction rules for major adverse outcomes in coronary bypass surgery (a comparison and methodological critique). Med Care. 2000;38(8):820–835
  2. Detre KM, Holmes DR, Holubkov R, Cowley MJ, Bourassa MG, Faxon DP, et al. Incidence and consequences of periprocedural occlusion (the 1985–1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry). Circulation. 1990;82:739–750
  3. Ellis SG, Roubin GS, King SB, Doublas JS, Weintraub WS, Thomas RG, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation. 1988;77:372–379
  4. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with antioplasty for multivessel coronary disease (implications for patient selection). Circulation. 1990;82:1193–1202
  5. De Feyter PJ, van den Brand M, Jaarman GJ, van Domburg R, Serruys PW, Suryapranata H. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty (frequency, prediction, clinical course, management, and follow-up). Circulation. 1991;83:927–936
  6. Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM. Results of percutaneous transluminal coronary angioplasty in women (1985–1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry). Circulation. 1993;87:720–727
  7. Bell MR, Holmes DR, Berger PB, Garratt KN, Bailey KR, Gersh BJ. The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty. JAMA. 1993;269:2091–2095
  8. Thompson RC, Holmes DR, Gersh BJ, Bailey KR. Predicting early and intermediate-term outcome of coronary angioplasty in the elderly. Circulation. 1993;88:1579–1587
  9. Gowda MS, Vacek JL, Hallas D. One-year outcomes of diabetic versus nondiabetic patients with non-Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty. Am J Cardiol. 1998;81(9):1067–1071
  10. Kimmel SE, Berlin JA, Strom BL, Laskey WK. Development and validation of a simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. J Am Coll Cardiol. 1995;26:931–938
  11. SAS Institute, Inc . Statistical analysis system (SAS). Cary, NC: SAS Institute, Inc.;; 1986;
  12. Harrell F. The LOGIST procedure. SAS supplemental library user's guide. Cary, NC: SAS Institute, Inc.;; 1980; p. 83–102.
  13. Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8:283–298
  14. Lemeshow S, Hosmer DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92–106
  15. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, Inc.;; 1989; p. 143.
  16. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA. 1997;277:488–494
  17. Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules. Applications and methodological standards. N Engl J Med. 1985;313:793–799
  18. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285–1293
  19. Ellis SG, Guetta V, Miller D, Whitlow PL, Topol EJ. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era (an analysis of results from 10,907 lesions and proposal for new classification scheme). Circulation. 1999;100(19):1971–1976
  20. Mathew V, Garratt KN, Holmes DR. Clinical outcome after multivessel coronary stent implantation. Am Heart J. 1999;138(6 Pt 1):1105–1110
  21. Laskey WK, Kimmel S, Krone RJ. Contemporary trends in coronary intervention (a report from the Registry of the Society for Cardiac Angiography and Interventions). Cathet Cardiovasc Intervent. 2000;49:19–22
  22. Block PC, Peterson ED, Krone R, Kesler K, Hannan E, O'Connor GT, et al. Identification of variables needed to risk adjust outcomes of coronary interventions (evidence-based guidelines for efficient data collection). J Am Coll Cardiol. 1998;32:275–282
  23. Harrell L, Schunkert EH, Palacios IF. Risk predictors in patients scheduled for percutaneous coronary revascularization. Cathet Cardiovasc Intervent. 1999;48:253–260

PII: S0895-4356(02)00538-3

Journal of Clinical Epidemiology
Volume 56, Issue 1 , Pages 17-27 , January 2003

Article Tools

* Image Usage & Resolution